C46.7 — Kaposi's sarcoma of other sites
Is C46.7 billable?
Yes — C46.7 is billable for FY2027. C46.7 is a valid, billable ICD-10-CM code at the highest level of specificity in its branch. C46.7 may be submitted for encounters from October 1, 2026 through September 30, 2027.
C46.7 at a glance
| Code | C46.7 |
|---|---|
| Description | Kaposi's sarcoma of other sites |
| Billable | Yes |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Which MS-DRGs does C46.7 group to?
C46.7 sits in MDC 09 and helps define the logic of 2 MS-DRGs (version 44, FY2027). Which one a stay actually groups to also depends on procedures and secondary diagnoses.
- 606Minor Skin Disorders with MCCmedical
- 607Minor Skin Disorders without MCCmedical
As a secondary diagnosis, C46.7 is a complication or comorbidity (CC), which can move a stay into a higher-paying DRG.
How is C46.7 listed in the Alphabetic Index?
These are the routes through the Alphabetic Index that lead to C46.7. They show the wording a clinician may have documented, which often differs from the Tabular description.
- Kaposi's › sarcoma › specified site NEC
- Sarcoma › Kaposi's › specified site NEC (of)
Code first — inherited from C46
The underlying condition below must be sequenced before C46.7. C46.7 describes a manifestation and cannot be the principal or first-listed diagnosis.
- any human immunodeficiency virus [HIV] disease (B20)
How long has C46.7 existed?
C46.7 has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.